SCHEMBL20780903

SCHEMBL20780903

C=C(O)c1nc(OC)sc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
POLB P06746 1/20 0.47
KDM4E B2RXH2 3/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HSD17B10 Q99714 1/20 0.46
ALOX5 P09917 4/20 0.42
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
GAA P10253 2/20 0.39
F2RL3 Q96RI0 1/20 0.39
MEN1 O00255 3/20 0.37
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GRM6 O15303 1/20 0.36
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13398512 0.84 KDM4E (0.52) ALDH1A1POLBKDM4EHPGDSMN1; SMN2
SCHEMBL20781049 0.83 ALDH1A1 (0.51) ALDH1A1POLBKDM4EHPGDSMN1; SMN2
SCHEMBL3318044 0.81 KDM4E (0.69) ALDH1A1POLBKDM4EHPGDSMN1; SMN2
SCHEMBL2189914 0.79 ALDH1A1 (0.51) ALDH1A1POLBKDM4EHPGDSMN1; SMN2
SCHEMBL20780902 0.75 ALOX5 (0.40) ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10
SCHEMBL7245046 0.71 ALDH1A1 (0.44) ALDH1A1POLBKDM4EHPGDSMN1; SMN2
SCHEMBL1340540 0.71 PIN1 (0.49) ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10
SCHEMBL984661 0.70 PIN1 (0.49) POLBSMN1; SMN2HCRTR1HCRTR2F2RL3
SCHEMBL20780956 0.69 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10
SCHEMBL20781137 0.69 ALDH1A1 (0.69) ALDH1A1POLBKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019043407-A1 SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS CHRONOS THERAPEUTICS LIMITED (GB) 2019-03-07 WO disclosed